Related Experiment Videos
Coffee and methylxanthines and breast cancer: a case-control study
Journal of the National Cancer Institute
|March 1, 1985
Summary
Coffee consumption showed a potential inverse association with breast cancer (BC) risk, particularly among high-fat consumers. Further research is needed to confirm these findings on methylxanthine intake and BC incidence.
Area of Science:
- Epidemiology
- Nutritional Science
- Oncology
Background:
- Dietary factors are crucial in breast cancer (BC) etiology.
- Methylxanthines, found in coffee and tea, have been investigated for their potential role in carcinogenesis.
- Previous research in animal models suggested caffeine might enhance mammary tumors in high-fat diets.
Purpose of the Study:
- To investigate the association between coffee and methylxanthine intake and breast cancer risk.
- To explore potential interactions between dietary fat consumption and methylxanthine intake in relation to BC.
- To compare methylxanthine consumption in breast cancer patients versus benign breast disease patients.
Main Methods:
- A dietary case-control study involving 818 newly diagnosed breast cancer patients in Israel (1975-1978).
- Comparison of methylxanthine intake (from coffee, tea, cola, chocolate) between BC patients and two control groups (surgical and neighborhood controls).
- Analysis stratified by fat consumption and adjusted for hormonal confounding factors.
Main Results:
- A nonsignificant inverse association was observed between higher coffee consumption (≥4 cups/day) and breast cancer risk (ORs 0.6-0.7).
- This inverse association was more pronounced among high-fat consumers (P-trend=0.05-0.06).
- Highest methylxanthine intake was associated with diminished BC risk compared to the lowest intake (OR=0.59) when compared to benign breast patients.
Conclusions:
- Coffee and methylxanthine consumption may be associated with a reduced risk of breast cancer.
- The potential protective effect might be stronger in individuals with high dietary fat intake.
- Further investigation is warranted to elucidate the role of methylxanthines in breast cancer development.